These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Progressive decrease of outflow gradient and septum thickness after percutaneous alcoholization of the interventricular septum in hypertrophic obstructive cardiomyopathy. Airoldi F; Di Mario C; Catanoso A; Dharmadhikari A; Tzifos V; Anzuini A; Carlino M; Briguori C; Montorfano M; Vaghetti M; Tolaro S; Colombo A Ital Heart J; 2000 Mar; 1(3):200-6. PubMed ID: 10806987 [TBL] [Abstract][Full Text] [Related]
26. [Percutaneous transluminal septal myocardial ablation in patients with hypertrophic obstructive cardiomyopathy: immediately and middle-term follow-up results]. Jiang T; Wu X; Jia C Zhonghua Nei Ke Za Zhi; 2001 Oct; 40(10):663-5. PubMed ID: 11769718 [TBL] [Abstract][Full Text] [Related]
27. [Long-term outcome of patients with hypertrophic obstructive cardiomyopathy post percutaneous transluminal septal ablation]. Zheng SW; Shi HY; Dai JJ; Chen H; Wu WH; Qiu XB Zhonghua Xin Xue Guan Bing Za Zhi; 2020 Apr; 48(4):294-301. PubMed ID: 32370480 [No Abstract] [Full Text] [Related]
28. Percutaneous versus surgical treatment for patients with hypertrophic obstructive cardiomyopathy and enlarged anterior mitral valve leaflets. van der Lee C; ten Cate FJ; Geleijnse ML; Kofflard MJ; Pedone C; van Herwerden LA; Biagini E; Vletter WB; Serruys PW Circulation; 2005 Jul; 112(4):482-8. PubMed ID: 16027255 [TBL] [Abstract][Full Text] [Related]
29. [Repeated percutaneous transluminal septal myocardial ablation leads to reduction of left ventricular outflow-tract pressure gradient in hypertrophic obstructive cardiomyopathy: a case report]. Takeda M; Mori T; Ohashi Y; Ichikawa S; Terashima M; Ejiri J; Awano K J Cardiol; 2006 Jun; 47(6):313-21. PubMed ID: 16800375 [TBL] [Abstract][Full Text] [Related]
31. Effect of septal ablation on regional diastolic dysfunction and diastolic asynchrony in patients with hypertrophic obstructive cardiomyopathy: a follow-up study using speckle tracking echocardiography. Chen S; Duan F; Yuan J; Qiao S; Lv X; Hu F; Yang W; Zhang J; Yang Y Echocardiography; 2013 May; 30(5):564-71. PubMed ID: 23305549 [TBL] [Abstract][Full Text] [Related]
32. Septal ethanol ablation for hypertrophic obstructive cardiomyopathy: early and intermediate results of a Canadian referral centre. Bhagwandeen R; Woo A; Ross J; Wigle ED; Rakowski H; Kwinter J; Eriksson MJ; Schwartz L Can J Cardiol; 2003 Jul; 19(8):912-7. PubMed ID: 12876612 [TBL] [Abstract][Full Text] [Related]
33. Use of percutaneous transluminal septal myocardial ablation for relief of outflow tract obstruction in cardiac amyloidosis: a novel therapeutic target. Murphy RT; Ratliff NB; Lever HM; Kapadia SR Catheter Cardiovasc Interv; 2006 Oct; 68(4):637-41. PubMed ID: 16969877 [TBL] [Abstract][Full Text] [Related]
34. Real-world clinical outcomes of percutaneous transluminal septal myocardial ablation for patients with drug-refractory hypertrophic obstructive cardiomyopathy: results from a retrospective multicenter registry of non-high-volume centers. Nakamura K; Toba T; Otake H; Kakizaki S; Fujimoto D; Takahashi Y; Fukuyama Y; Kawamori H; Tanaka H; Takaya T; Iwasaki M; Kozuki A; Kawai H; Hayashi T; Shite J; Hirata KI Heart Vessels; 2022 Nov; 37(11):1937-1946. PubMed ID: 35641828 [TBL] [Abstract][Full Text] [Related]
35. [Non-drug treatment for hypertrophic obstructive cardiomyopathy in children]. Zhang X; Li YF; Xie B; Chen JY; Qian MY Zhonghua Er Ke Za Zhi; 2011 May; 49(5):381-5. PubMed ID: 21624293 [TBL] [Abstract][Full Text] [Related]
36. Comparison of Clinical Effects between Percutaneous Transluminal Septal Myocardial Ablation and Modified Morrow Septal Myectomy on Patients with Hypertrophic Cardiomyopathy. Guo HC; Li JH; Jiang TY; Ren CW; Dai J; Zhou YJ; Lai YQ Chin Med J (Engl); 2018 Mar; 131(5):527-531. PubMed ID: 29483385 [TBL] [Abstract][Full Text] [Related]